TrialInvestigational new drugs2009

A phase II study of S-1 plus irinotecan and oxaliplatin in heavily-treated patients with metastatic colorectal cancer.

Sun Young Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.